Zoledronic Acid
Back to searchMolecule Structure
Scientific Name
Zoledronic Acid
Description of the Drug
Zoledronic acid is a bisphosphonate used to treat malignancy associated hypercalcemia, multiple myeloma, and bone metastasis from solid tumors.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00399
http://www.drugbank.ca/drugs/DB00399
Brand Name(s)
Aclasta, Reclast, Zerlinda, Zoledronic acid, Zometa
Company Owner(s)
Inforlife Sa, Actavis Inc, Amneal Eu Ltd, Novartis Pharmaceuticals Corp, Emcure Pharmaceuticals Ltd, Akorn Operating Co Llc, Hikma Farmaceutica Sa, Sun Pharma Global Fze, Ingenus Pharmaceuticals Llc, Fresenius Kabi Usa Llc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Farnesyl diphosphate synthase | SINGLE PROTEIN | INHIBITOR | CHEMBL1782 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL19054 | |||
PharmGKB | PA10235 | |||
Human Metabolome Database | HMDB0014543 | |||
DrugBank | DB00399 | |||
PubChem: Thomson Pharma | 14824151 | |||
PubChem | 68740 | |||
Mcule | MCULE-1604726355 | |||
Nikkaji | J556.181G | |||
PDBe | ZOL | |||
BindingDB | 12578 | |||
EPA CompTox Dashboard | DTXSID0042668 | |||
DrugCentral | 2868 | |||
Brenda | 6184 | 189166 | ||
ChemicalBook | CB4395643 | |||
Guide to Pharmacology | 3177 | |||
rxnorm | ZOMETA | ZOLEDRONIC ACID ANHYDROUS | RECLAST | ZOLEDRONIC ACID |
ChEBI | 46557 | |||
ZINC | ZINC000003803652 |